Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Should You Buy?
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Should You Buy?

Axsome Therapeutics (AXSM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Haverty Furniture (HVT) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Haverty Furniture (HVT) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Haverty Furniture (HVT) reports results for the quarter ended December 2025. While this widely-known consensus

Adyen (ADYEY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Adyen (ADYEY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Adyen N.V. Unsponsored ADR (ADYEY) has been bearish lately and the stock has lost 20.2% over the past week. However, the formation of a hammer chart pattern in its last trading

Calix (CALX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Calix (CALX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Shares of Calix (CALX) have been struggling lately and have lost 8.2% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Stantec (STN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Stantec (STN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Shares of Stantec (STN) have been struggling lately and have lost 14.3% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock

ServisFirst Bancshares (SFBS)'s Technical Outlook is Bright After Key Golden Cross
ServisFirst Bancshares (SFBS)'s Technical Outlook is Bright After Key Golden Cross

ServisFirst Bancshares, Inc. (SFBS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SFBS's 50-day simple moving average broke out

Goldman (GS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Goldman (GS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in Goldman Sachs (GS) lately. While the stock has lost 5.9% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last

Sandisk's AI-Linked SSD Growth Continues: A Sign of More Upside?Photo, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Sandisk's AI-Linked SSD Growth Continues: A Sign of More Upside?

Sandisk Corporation SNDK is benefiting from a structural shift in enterprise solid-state drive demand as AI workloads redefine storage priorities inside data centers. Customers are no longer

What's in Store For These 5 Construction Stocks This Earnings Season?
What's in Store For These 5 Construction Stocks This Earnings Season?

Heading into the upcoming earnings cycle, the United States construction sector is at crossroads, with housing softness counterbalanced by resilient infrastructure and public works demand. On one

J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of

Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead?
Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead?

Shares of Prothena Corporation PRTA have plunged 36.8% over the past year against the industry’s 19.6% rise.

The decline can be attributed to pipeline setbacks, most notably the failure and

Strength in Defense & Propulsion Unit Drives GE Aerospace: Can It Sustain?Photo, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Strength in Defense & Propulsion Unit Drives GE Aerospace: Can It Sustain?

GE Aerospace GE is benefiting from solid momentum in its Defense & Propulsion Technologies segment. Growing popularity for the company’s propulsion & additive technologies, critical aircraft systems

Why Westinghouse Air Brake Technologies (WAB) is a Top Momentum Stock for the Long-Term
Why Westinghouse Air Brake Technologies (WAB) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why JB Hunt (JBHT) is a Strong Momentum Stock
Here's Why JB Hunt (JBHT) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Iridium Communications (IRDM) is a Top-Ranked Momentum Stock: Should You Buy?
Iridium Communications (IRDM) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why General Motors (GM) is a Top Momentum Stock for the Long-Term
Why General Motors (GM) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Nucor (NUE) is a Strong Momentum Stock
Here's Why Nucor (NUE) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why Magna (MGA) is a Top Momentum Stock for the Long-Term
Why Magna (MGA) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why Fifth Third Bancorp (FITB) is a Strong Momentum Stock
Here's Why Fifth Third Bancorp (FITB) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Cincinnati Financial (CINF) is a Strong Momentum Stock
Here's Why Cincinnati Financial (CINF) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why AbbVie (ABBV) is a Top Momentum Stock for the Long-Term
Why AbbVie (ABBV) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Ecolab (ECL) is a Top-Ranked Momentum Stock: Should You Buy?
Ecolab (ECL) is a Top-Ranked Momentum Stock: Should You Buy?

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Coca-Cola's Q4 Metrics Signal Growth or Slowing Momentum?
Coca-Cola's Q4 Metrics Signal Growth or Slowing Momentum?

The Coca-Cola Company’s KO fourth-quarter 2025 results continued to exhibit growth along with signs of moderating momentum. The company’s revenues and earnings per share (EPS) improved year over

Should First Majestic Silver Stock be in Your Portfolio Pre-Q4 Earnings?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Should First Majestic Silver Stock be in Your Portfolio Pre-Q4 Earnings?

First Majestic Silver Corp. AG is scheduled to release fourth-quarter 2025 results on Feb. 19. The Zacks Consensus Estimate for its quarterly earnings is currently pegged at 27 cents per share.The